This document discusses clinical nursing research in India. It begins by stating that in 2012, 55% of nursing practices in the USA were based on research findings, and the ANA predicts this will rise to 90% by 2020. In India, key organizations that support nursing research include the Nursing Research Society of India and the Clinical Nursing Research Society. The document defines clinical nursing research and explains why it is important for evidence-based practice and improving patient outcomes. It also discusses the roles of nurses in clinical research, common research designs, and challenges in conducting this type of research.
At the end of this presentation you will be able to:
Define evidence-based practice
Describe process & outline steps of EBP
Understand PICO elements & search strategy
Identify resources to support EBP
The focus of this presentation is nursing practice, although it is still of value to physicians and other health care professionals.
MEDICAL AUDIT
Evaluation of data, documents, and resources to check performance of systems meets specified standards
PRESCRIPTION MONITORING, ADR, DRUG RELATED PROBLEMS, staff safety, data,defining standards,
collecting data,
identifying areas for improvement,
making necessary changes
back round to defining new standards.
At the end of this presentation you will be able to:
Define evidence-based practice
Describe process & outline steps of EBP
Understand PICO elements & search strategy
Identify resources to support EBP
The focus of this presentation is nursing practice, although it is still of value to physicians and other health care professionals.
MEDICAL AUDIT
Evaluation of data, documents, and resources to check performance of systems meets specified standards
PRESCRIPTION MONITORING, ADR, DRUG RELATED PROBLEMS, staff safety, data,defining standards,
collecting data,
identifying areas for improvement,
making necessary changes
back round to defining new standards.
Let's Talk Research Annual Conference - 24th-25th September 2014 (Gail Woodburn)NHSNWRD
"Maximising the potential of the clinical research nurse workforce in order to promote research and innovation": Gail Woodburn's presentation from the conference.
The challenges faced by nursing administrators are many and varies. An overview of such challenges will be helpful in working towards the managerial solutions.
Nursing administration is very complex and requires many problems to be faced and managed in the current day practice. An overview of the challenges in nursing administration are presented in the slides
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
6. What is the Percentage of nursing practices
based on research findings in India?
7. It’s a trend !
• In 2012 USA 55% of all nursing
practices are based on research
findings.
• The American Nurses Association
(ANA) predicts that by 2020, 90% of all
nursing practice will be based on EBP
research findings.
8. Indian perspectives
• Nursing research Society of India
• Clinical Nursing Research Society in India
–Visit www.cnrsi.in
• TamilNadu Nurses and Midwives Council
–Nursing Research Archives
9. What is Clinical Nursing Research
Clinical research is a branch of healthcare science that determines the
safety and effectiveness (efficacy) of medications, devices, diagnostic
products and treatment regimens intended for human use.
These may be used for prevention, treatment, diagnosis or for relieving
symptoms of a disease.
Clinical nursing research is a systematic inquiry into the problems
encountered in nursing practice and into the modalities of patient care.
10. Myths around CNR…..
Clinical research Vs Clinical trials
EBP is not synonymous with research.
• Research focuses on discovery
• EBP focuses on application
Clinical Nursing Research is not synonymous with Nursing
Audit
12. Why clinical nursing research is important
to nursing practice?
• It results in better patient outcomes.
• It contributes to the science of nursing.
• It keeps practice current and relevant.
• It increases confidence in decision making.
• Policies and procedures are current and include
the latest research, thus supporting JCAHO-
readiness.
14. Why Nurses?
• Critical members of the patient care team
• Empathy, sympathy and noble fellow beings.
• Closer to the participants/patients
• Care and research are a continuum .
• Patience and good interpersonal relationships.
• Recognized globally nurses play a important role in emancipating
quality care by research and quality framework.
21. Clinical Nursing Research Priorities
Effective work force
• Evaluating the competency frameworks
• Nurse :Patient Ratios etc..
• exploration of different models of care delivery
• program development
Effective clinical outcomes/ clinical governance
• Clinical innovation
• Optimising patient outcomes
• Systems & process evaluation
• Integration of evidence into practice
• Quality improvement initiatives eg. Lean six sigma for waste reduction
22. CNR priorities ….contd
Positive experiences/colloborations
• the process of developing of partnerships with consumers
• fostering engagement with patients and families to participate in their own care
• the impact of disease processes and interventions upon the quality of life for
patients and their families.
Patient safety and Zero Harm
• Incident review
• Development of Policies and protocols
• Systems analysis
• Clinical risk management
• Product development
23.
24. Steps in Clinical Research
Formulating the
research question
based on day to
day care
Defining the
purpose of the
study
Reviewing related
literature and
Formulating
hypotheses and
defining variables
Selecting the
research design,
sample setting
Conducting a pilot
study
Collecting and
analyzing the data
Change of
practice towards
quality
improvement.
25. Regulations
• The Clinical Trials Registry- India (CTRI) has been set up
by the ICMR's National Institute of Medical Statistics
(NIMS) and is funded by the Department of Science and
Technology (DST) through the Indian Council of Medical
Research (ICMR).
• Institutional ethics committee – Registration with
CDSCO/DCGI
28. Referenced Rationale & Quality of Evidence Rating Contd-
• The PICOT format
28
Elements
Participants Newborn babies with Vernix Caseosa
Intervention is it really works out the baby’s skin?
Comparison Compared with its properties.
Outcome Protection against infection, Decreased
Skin permeability, Skin cleansing,
Moisturisation the skin Surface
PH Development ,Wound Healing.
Timeframe During Postnatal period
29. Clinical Nursing Research Designs
Qualitative
research
Lean Six
Sigma
Experimental
research
designs
• Pre
experimental,
Quasi
experimental,
RCT
Analytical
studies
• Case control studies
• Cohort studies
• Epidemiological
studies
Descriptive
designs
• Surveys,
• correlational studies
30.
31.
32. Cochrane Database of Systematic
Reviews
• The Cochrane Database of Systematic Reviews (CDSR)
is the leading journal and database for systematic reviews
in health care. CDSR includes Cochrane Reviews
(systematic reviews) and protocols for Cochrane Reviews
as well as editorials and supplements.
• CDSR (ISSN 1469-493X) is owned and produced by
Cochrane, a global, independent network of researchers,
professionals, patients, carers, and people interested in
health.
33. Challenges in Clinical Nursing Research
Navigating
Organizational
restructuring
Managing
with the
uncertainty
Creating
reciprocity
Controlling
Extraneous
variables
Working with
Economic
Constraints